ArticleAmerican journal of translational research2016

Farnesoid X receptor ligand CDCA suppresses human prostate cancer cells growth by inhibiting lipid metabolism via targeting sterol response element binding protein 1.

Nian Liu et al.PubMed ↗Full text ↗

No numbers read from the abstract.